CPA
PODD icon

Capital Performance Advisors’s Insulet PODD Stock Holding History

Capital Performance Advisors’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,125
Closed -$236K – 452
2026
Q1 		$236K Buy
+1,125
New +$283K 0.02% 393
2024
Q4 		– Sell
-104
Closed -$24.1K – 2011
2024
Q3 		$24.1K Buy
+104
New +$21.4K 0.01% 551

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital Performance Advisors's PODD Position: Q2 2026 in Review

Capital Performance Advisors sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,125 shares — an estimated $236K sold.

Capital Performance Advisors first reported a position in PODD in Q3 2024 and held it in 2 quarters. The position peaked at $236K in Q1 2026. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Capital Performance Advisors reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Capital Performance Advisors sold 1,125 Insulet shares in Q2 2026, an estimated $236K.
  • Capital Performance Advisors first reported a position in Insulet in Q3 2024 and held it in 2 quarters.
  • Capital Performance Advisors's Insulet position peaked at $236K in Q1 2026.
  • 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.